The challenge is to stifle the binding of inhibitory antibodies but retain activity of a blood enzyme.
UAB’s ongoing research for countermeasures to bromine or chlorine exposure — from either industrial spills or chemical attack — gets a boost with a new NIH grant.
The mimicry of bone cells by multiple myeloma is driven by overexpression of Runx2, the master regulator of bone formation.
Ona Faye‐Petersen, M.D., a professor of Pathology with joint appointment in the Department of Obstetrics and Gynecology, has been named president‐elect of the Society for Pediatric Pathology.
Thirty students from universities across the country are participating this summer in the Summer in Biomedical Sciences Undergraduate Research Program and the Preparation for Graduate and Medical Education programs.
Four projects were awarded through the first School of Medicine AMC21 Reload Multi-Investigator Grants, a broad funding opportunity provided through the Academic Enrichment Fund that enables faculty members to organize and integrate multi-disciplinary teams of accomplished investigators to compete successfully for long-term extramural support.
Mary T. Hawn, M.D., and Robin G. Lorenz, M.D., Ph.D., recently completed fellowships in the Hedwig van Ameringen Executive Leadership in Academic Medicine® program.
UAB discovery gives better understanding of and potential therapies for septic shock and reperfusion injuries.
Elevated PARP1 polymerase in HER2+ breast cancer may confer susceptibility to PARP inhibitor drugs.
Similar to the ancient Greek legend of the Trojan horse, platelets in a transgenic mouse deliver a life-saving enzyme.
Page 1 of 3